The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for LifeSign sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
LifeSign is a medical diagnostic company that delivers quality and rapid point-of-care testing solutions to the healthcare industry. The company’s products include various testing solutions such as markers, rapid tests, controls, and incubators. Its products are used worldwide for the detection of medical conditions and illnesses which comprise women’s health, infectious disease, drugs of abuse, and cardiac markers. The company’s products find application in critical care, physicians, offices, schools, the workplace, criminal justice, ships, ambulances, and home. It also offers products for rapid monitoring of microbial contamination in industrial environments. LifeSign is headquartered in Skillman, New Jersey, the US.
The key metrics of LifeSign related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As LifeSign is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as LifeSign.
For a detailed understanding of the performance of LifeSign, buy the report here.